AlJadaan: Leaders of Gulf Countries are Keen for Gulf Cooperation Council to Reach Highest Levels of Economic Integration    1.5m clients benefit from digital conveyance of title deeds service    Umrah companies obligated to issue permits for its pilgrims    Saudi Arabia retains its seat in ITU Council by international consensus    RCU launches Safar art exhibition at AlUla airport    Iran's supreme leader blames unrest on US and Israel    Speaker of Shura Council Heads Kingdom's Delegation to 8th G20 Parliamentary Speakers' Summit in Jakarta    Saudi Stock Exchange Main Index Ends Trading Higher at 11,607.96 Points    Saudi Minister of Commerce Heads Delegation to Morocco, Discusses Enhancing Commercial, Investment Relations    Qatar Stock Exchange Ends Trading Higher    Saudi Arabia to host World Petroleum Congress in 2026    Jazan International Forum moots Saudi Coffee Day, Annual Coffee Award    Sultan Humanitarian City wins platinum award at 2022 Patient Safety Congress in Dubai    King, Crown Prince congratulate German president on Unity Day    Brazil election: Lula and Bolsonaro to face run-off    UK chancellor U-turns on plans to scrap tax rate    Record avian flu outbreak sees 48 million birds culled in UK and EU    Fans 'died in the arms' of players in Indonesia stadium crush    Fans of Sydney United 58 condemned for Nazi salutes during Australia Cup final    Tadawul All Share Index Decreases by 0.79%, Equity Market Capitalization Reaches SAR 10,832.85 Billion at End of 1st Nine Months 2022    Asian Shares Mostly Lower    Weather Forecast for Monday    KSrelief Concludes the 11th, 12th Volunteer Program in Zaatari Camp for Syrian Refugees in Jordan    flynas Launches the "Future Engineers Program" for Aircraft Engineering and Maintenance with 300 Saudi Engineers in Its First Batch    Al-Manea: Selling gold in installments is not permissible    MAWANI, Tabadul Sign MoU to Develop New Saudi Ports Management Systems    174 dead in Indonesian football stadium crush    At Least 127 People Killed, 180 Injured at Football Match in Indonesia    15 cups of Saudi coffee in a day are enough!    Riyadh hosts first Saudi Games on Oct. 27    19 women, 2 men qualify as Kingdom's first yogasana referees    Movies return to Kashmir with Hrithik Roshan-starrer    Body of famed US climber found on Mt Manaslu in Himalayas    Yoga introduced to Saudi universities    Islamic Minister Al-Sheikh: Juristic judgment catalyst to salvage Islamic Ummah    Culinary Arts Commission Registers 13 Foods on Slow Food List of Endangered Food    72% of Children Globally have been Victims of Cyber Threats    Saudi National Football Team Continues Preparations for Friendly Match against Ecuador    Saudi Futsal Team Beats San Marino, Wins Silver in Croatian International Championship    During 2nd Global AI Summit.. AI-powered Early Breast Cancer Detection Program Launched    Triple talaq: India Muslim women in limbo after instant divorce ruling    Film Commission Reviews Film Industry Prospects in Saudi Arabia at Venice International Film Festival    Saudi national volleyball team loses to Kyrgyzstan in Asian Challenge Cup final    Saudi national volleyball team beats Uzbekistan, qualifies for the final of the Asian Challenge Cup    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Pfizer seeks a nod for booster shot, works on new COVID-19 vaccine for Delta variant
Published in The Saudi Gazette on 09 - 07 - 2021

Drugmaker Pfizer said Thursday it is seeing waning immunity from its coronavirus vaccine and says it is picking up its efforts to develop a booster dose that will protect people from variants.
Pfizer said it would soon publish data about a third dose of vaccine and submit it to the US Food and Drug Administration, European Medicines Agency and other regulators. The company specified it would seek FDA emergency use authorization for a booster dose in August.
But in an unusual move, two top federal agencies said Americans don't need boosters yet and said it was not up to companies alone to decide when they might be needed.
Hours after Pfizer issued its statement, the FDA and Centers for Disease and Control issued a joint statement saying Americans do not need booster shots yet.
"Americans who have been fully vaccinated do not need a booster shot at this time," they said.
In a statement to CNN on Friday, the World Health Organization said, "We don't know whether booster vaccines will be needed to maintain protection against COVID-19 until additional data is collected," adding, "limited data available on how long the protection from current doses lasts and whether an additional booster dose would be beneficial and for whom."
Pfizer and its partner BioNTech said evidence was building that people's immunity starts to wane after they have been vaccinated. The Pfizer vaccine requires two doses to provide full immunity.
"As seen in real-world data released from the Israel Ministry of Health, vaccine efficacy in preventing both infection and symptomatic disease has declined six months post-vaccination, although efficacy in preventing serious illnesses remains high," Pfizer said in a statement.
"Additionally, during this period the Delta variant is becoming the dominant variant in Israel as well as many other countries. These findings are consistent with an ongoing analysis from the Companies' Phase 3 study," it added.
"While protection against severe disease remained high across the full six months, a decline in efficacy against symptomatic disease over time and the continued emergence of variants are expected.
Based on the totality of the data they have to date, Pfizer and BioNTech believe that a third dose may be beneficial within 6 to 12 months following the second dose to maintain highest levels of protection."
It gave no further details.
The announcement could have implications across the world. The Pfizer shot is the cornerstone of vaccination programs in many countries. Two-thirds of doses delivered across the European Union were made by Pfizer, according to the European Center. In Israel, Pfizer is the only vaccine used.
Of the 158 million fully vaccinated people in the US, more than half received the Pfizer shot.
US government officials have stressed that fully vaccinated people have a low risk of infection, even from the Delta or B.1.617.2 variant, which is more transmissible than earlier lineages of the virus.
Plus, several studies have indicated the mRNA vaccines made by Pfizer and Moderna confer long-term protection.
"FDA, CDC, and NIH (the National Institutes of Health) are engaged in a science-based, rigorous process to consider whether or when a booster might be necessary. This process takes into account laboratory data, clinical trial data, and cohort data -- which can include data from specific pharmaceutical companies, but does not rely on those data exclusively," they added.
It was a clear message to Pfizer, which has been hinting at the need for a booster shot for months.
"We continue to review any new data as it becomes available and will keep the public informed. We are prepared for booster doses if and when the science demonstrates that they are needed," the CDC and FDA said in the statement.
"The United States is fortunate to have highly effective vaccines that are widely available for those aged 12 and up. People who are fully vaccinated are protected from severe disease and death, including from the variants currently circulating in the country such as Delta," the statement continued.
"People who are not vaccinated remain at risk. Virtually all COVID-19 hospitalizations and deaths are among those who are unvaccinated. We encourage Americans who have not yet been vaccinated to get vaccinated as soon as possible to protect themselves and their community."
Israel's health ministry said in a statement earlier this week that it had seen the efficacy of Pfizer's vaccine drop from more than 90 percent to about 64 percent as the B.1.617.2 or Delta variant spread.
Pfizer said research showed booster doses of its vaccine, developed with BioNTech, produced levels of neutralizing antibodies that are five to 10 times higher than what's produced after two doses.
It said it's also developing a new formulation for a booster dose that may more thoroughly protect people from new variants.
"While Pfizer and BioNTech believe a third dose of BNT162b2 has the potential to preserve the highest levels of protective efficacy against all currently known variants including Delta, the companies are remaining vigilant and are developing an updated version of the Pfizer-BioNTech COVID-19 vaccine that targets the full spike protein of the Delta variant," the company said. Current vaccines target just a piece of the spike protein — the part of the virus it uses to attach to cells.
"The first batch of the mRNA for the trial has already been manufactured at BioNTech's facility in Mainz, Germany. The Companies anticipate the clinical studies to begin in August, subject to regulatory approvals." — CNN


Clic here to read the story from its source.